These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33074551)

  • 1. Vancomycin MIC and agr dysfunction in invasive MRSA infections in southern Brazil.
    Rossato AM; Primon-Barros M; Dias CAG; d'Azevedo PA
    Braz J Microbiol; 2020 Dec; 51(4):1819-1823. PubMed ID: 33074551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accessory Gene Regulator Polymorphism and Vancomycin Minimum Inhibitory Concentration in Methicillin-Resistant Staphylococcus aureus.
    Park MJ; Kim HS; Kim HS; Kim JS; Song W; Kim MY; Lee YK; Kang HJ
    Ann Lab Med; 2015 Jul; 35(4):399-403. PubMed ID: 26131410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of staphyloccocus aureus.
    Harigaya Y; Ngo D; Lesse AJ; Huang V; Tsuji BT
    BMC Infect Dis; 2011 Oct; 11():287. PubMed ID: 22026752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic changes of methicillin-resistant Staphylococcus aureus during vancomycin therapy for persistent bacteraemia and related clinical outcome.
    Kim T; Kim ES; Park SY; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Chong YP; Kim YS
    Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1473-1481. PubMed ID: 28337607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey.
    Sancak B; Yagci S; Gür D; Gülay Z; Ogunc D; Söyletir G; Yalcin AN; Dündar DO; Topçu AW; Aksit F; Usluer G; Ozakin C; Akalin H; Hayran M; Korten V
    BMC Infect Dis; 2013 Dec; 13():583. PubMed ID: 24325260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a clinical association of vancomycin MIC creep, agr group II locus, and treatment failure in MRSA bacteremia?
    de Sanctis JT; Swami A; Sawarynski K; Gerasymchuk L; Powell K; Robinson-Dunn B; Carpenter CF; Sims MD
    Diagn Mol Pathol; 2011 Sep; 20(3):184-8. PubMed ID: 21817905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections.
    Butterfield JM; Tsuji BT; Brown J; Ashley ED; Hardy D; Brown K; Forrest A; Lodise TP
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5433-7. PubMed ID: 21930887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of SCCmec type V and agr type I among heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in north India.
    Singh A; Prasad KN; Rahman M; Rai RP; Singh SK; Srivastava JK
    J Glob Antimicrob Resist; 2017 Mar; 8():110-114. PubMed ID: 28109847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of accessory gene regulator (agr) dysfunction on vancomycin pharmacodynamics among Canadian community and health-care associated methicillin-resistant Staphylococcus aureus.
    Tsuji BT; MacLean RD; Dresser LD; McGavin MJ; Simor AE
    Ann Clin Microbiol Antimicrob; 2011 May; 10():20. PubMed ID: 21599878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and accessory gene regulator (agr) analysis of vancomycin-intermediate Staphylococcus aureus among methicillin-resistant isolates in Taiwan--SMART program, 2003.
    Ho CM; Hsueh PR; Liu CY; Lee SY; Chiueh TS; Shyr JM; Tsao SM; Chuang YC; Yan JJ; Wang LS; Wang JH; Ho MW; Tien N; Lu JJ
    Eur J Clin Microbiol Infect Dis; 2010 Apr; 29(4):383-9. PubMed ID: 20155296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013.
    Huang SH; Chen YC; Chuang YC; Chiu SK; Fung CP; Lu PL; Wang LS; Wu TL; Wang JT
    J Microbiol Immunol Infect; 2016 Oct; 49(5):701-707. PubMed ID: 26320398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
    Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
    J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in meticillin-resistant S. aureus bacteraemia patients.
    Wang JL; Lai CH; Lin HH; Chen WF; Shih YC; Hung CH
    Int J Antimicrob Agents; 2013 Nov; 42(5):390-4. PubMed ID: 24041465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates.
    Pitz AM; Yu F; Hermsen ED; Rupp ME; Fey PD; Olsen KM
    J Clin Microbiol; 2011 Jan; 49(1):269-74. PubMed ID: 20962147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of a globally disseminated hypervirulent clone, Staphylococcus aureus CC121, with reduced vancomycin susceptibility in community settings in China.
    Shen P; Zhou K; Wang Y; Song J; Liu Y; Zhou Y; Xiao Y
    J Antimicrob Chemother; 2019 Sep; 74(9):2537-2543. PubMed ID: 31203362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accessory gene regulator (agr) dysfunction in Staphylococcus aureus bloodstream isolates from South Korean patients.
    Chong YP; Kim ES; Park SJ; Park KH; Kim T; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Jeong JY; Kim YS
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1509-12. PubMed ID: 23254438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trend in vancomycin susceptibility and correlation with molecular characteristics of methicillin-resistant Staphylococcus aureus causing invasive infections in Taiwan: results from the Tigecycline in vitro Surveillance in Taiwan (TIST) study, 2006-2010.
    Tsao SM; Wang WY; Ko WC; Huang CH; Lu CT; Chuang YC; Liu CY; Liao CH; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Liu JW; Sun W; Wang LS; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Chen YH; Lu PL; Thomas CY; Hsueh PR
    Diagn Microbiol Infect Dis; 2014 Oct; 80(2):162-7. PubMed ID: 25053202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early agr activation correlates with vancomycin treatment failure in multi-clonotype MRSA endovascular infections.
    Abdelhady W; Chen L; Bayer AS; Seidl K; Yeaman MR; Kreiswirth BN; Xiong YQ
    J Antimicrob Chemother; 2015 May; 70(5):1443-52. PubMed ID: 25564565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Microbiological Characteristics of qacA/B-Positive Methicillin-Resistant Staphylococcus aureus Isolates in a Surgical Intensive Care Unit.
    Cho OH; Park KH; Song JY; Hong JM; Kim T; Hong SI; Kim S; Bae IG
    Microb Drug Resist; 2018 Apr; 24(3):283-289. PubMed ID: 28799881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of agr expression and function with virulence and vancomycin treatment outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Seidl K; Chen L; Bayer AS; Hady WA; Kreiswirth BN; Xiong YQ
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5631-9. PubMed ID: 21968365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.